OTC : AOXG

Aoxing Pharmaceutical Company, Inc.

$0.0035 USD

$0 (0.0%)

Volume
230
Average Volume
5.21K
Market Capitalization
$266.76K
P/E Ratio
-86.98
Dividend Yield
0.00%
Price Target
Year High
$0.01
Year Low
$0.00
Day High
Day Low
Payout Ratio
$0.00
Current Ratio
$0.96

AOXG Financial

date 2025-06-30 2024-06-30
revenue - -
costOfRevenue - -
grossProfit - -
researchAndDevelopmentExpenses - -
generalAndAdministrativeExpenses - -
sellingAndMarketingExpenses - -
sellingGeneralAndAdministrativeExpenses 7300 14825
otherExpenses - -
operatingExpenses 7300 14825
costAndExpenses 7300 14825
netInterestIncome - -
interestIncome - -
interestExpense - -
depreciationAndAmortization - 167.9K
ebitda 55240 -14820
ebit 55240 -14825
nonOperatingIncomeExcludingInterest -62540 5
operatingIncome -7300 -14820
totalOtherIncomeExpensesNet 62538 -5
incomeBeforeTax 55238 -14825
incomeTaxExpense - -
netIncomeFromContinuingOperations 55238 -14825
netIncomeFromDiscontinuedOperations - -
otherAdjustmentsToNetIncome - -
netIncome 55238 -14825
netIncomeDeductions - -
bottomLineNetIncome 55238 -14825
eps 0.0 -0.0
date 2024-06-30
netIncome -14825
depreciationAndAmortization -
deferredIncomeTax -
stockBasedCompensation -
changeInWorkingCapital 14825
accountsReceivables -
inventory -
accountsPayables -
otherWorkingCapital 14825
otherNonCashItems -14825
netCashProvidedByOperatingActivities -14825
investmentsInPropertyPlantAndEquipment -
acquisitionsNet -
purchasesOfInvestments -
salesMaturitiesOfInvestments -
otherInvestingActivities -
netCashProvidedByInvestingActivities -
netDebtIssuance -
longTermNetDebtIssuance -
shortTermNetDebtIssuance -
netStockIssuance -
netCommonStockIssuance -
commonStockIssuance -
commonStockRepurchased -
netPreferredStockIssuance -
netDividendsPaid -
commonDividendsPaid -
preferredDividendsPaid -
otherFinancingActivities 14825
netCashProvidedByFinancingActivities 14825
date 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30
revenue 17212 2080 - - - - - - - -
costOfRevenue 214.37 - - - - - - - - -
grossProfit 16997 - - - - - - - - -
researchAndDevelopmentExpenses - - - - - - - - - -
generalAndAdministrativeExpenses - - - - - - - - - -
sellingAndMarketingExpenses - - - - - - - - - -
sellingGeneralAndAdministrativeExpenses 28197 4519 900 800 5600 1625 400 1018 4682 8725
otherExpenses - - - - - - - - - -
operatingExpenses 28197 4519 900 800 5600 1625 400 1018 4682 8725
costAndExpenses 28411 4519 900 800 5600 -1625 400 1018 4682 8725
netInterestIncome - - - - - - - - - -
interestIncome - - - - - - - - - -
interestExpense - - - - - - - - - -
depreciationAndAmortization - - - - - - 43812 -39586 122.08K 41584
ebitda -11199 -2439 -900 -800 56938 -1625 43412 -1020.0 -4680 -8720
ebit -11199 -2439 -900 -800 56938 -1625 -400 -1018 -4682 -8725
nonOperatingIncomeExcludingInterest - - - - -62538 - - -2.0 2 5
operatingIncome -11199 -2439 -900 -800 -5600 -1625 -400 -1020.0 -4680 -8720
totalOtherIncomeExpensesNet - - - - 62538 - - 2.0 -2 -5
incomeBeforeTax -11201 -2438 -900 -800 56938 -1625 -400 -1018 -4682 -8725
incomeTaxExpense - - - - - - - - - -
netIncomeFromContinuingOperations -11201 -2438 -900 -800 56938 -1625 -400 -1018 -4682 -8725
netIncomeFromDiscontinuedOperations - - - - - - - - - -
otherAdjustmentsToNetIncome - - - - - - - - - -
netIncome -11201 -2438 -900 -800 56938 -1625 -400 -1018 -4682 -8725
netIncomeDeductions - - - - - - - - - -
bottomLineNetIncome -11201 -2438 -900 -800 56938 -1625 -400 -1018 -4682 -8725
eps - - - - - -0.0 -0.0 -0.0 -0.0 -0.0
date 2025-12-31 2025-09-30
cashAndCashEquivalents 23829 23941
shortTermInvestments - -
cashAndShortTermInvestments 23829 23941
netReceivables - -
accountsReceivables - -
otherReceivables - -
inventory - -
prepaids - -
otherCurrentAssets 102.05K 102.05K
totalCurrentAssets 125.88K 125.99K
propertyPlantEquipmentNet - -
goodwill - -
intangibleAssets - -
goodwillAndIntangibleAssets - -
longTermInvestments - -
taxAssets - -
otherNonCurrentAssets - -
totalNonCurrentAssets - -
otherAssets - -
totalAssets 125.88K 125.99K
totalPayables - -
accountPayables - -
otherPayables - -
accruedExpenses - -
shortTermDebt 102.87K 102.18K
capitalLeaseObligationsCurrent - -
taxPayables - -
deferredRevenue - -
otherCurrentLiabilities 28476 18076
totalCurrentLiabilities 131.34K 120.26K
longTermDebt - -
capitalLeaseObligationsNonCurrent - -
deferredRevenueNonCurrent - -
deferredTaxLiabilitiesNonCurrent - -
otherNonCurrentLiabilities - -
totalNonCurrentLiabilities - -
otherLiabilities - -
capitalLeaseObligations - -
totalLiabilities 131.34K 120.26K
treasuryStock - -
preferredStock - -
commonStock 38121 38121
retainedEarnings -73.69M -73.68M
additionalPaidInCapital 73.65M 73.65M
date 2025-12-31 2025-09-30 2024-06-30
netIncome -11201 -2438 -400
depreciationAndAmortization - - -
deferredIncomeTax - - -
stockBasedCompensation - - -
changeInWorkingCapital 10400 -101.95K 400
accountsReceivables - - -
inventory - - -
accountsPayables - - -
otherWorkingCapital 10400 -101.95K 400
otherNonCashItems - - -14825
netCashProvidedByOperatingActivities -801 -104.39K -14825
investmentsInPropertyPlantAndEquipment - - -
acquisitionsNet - - -
purchasesOfInvestments - - -
salesMaturitiesOfInvestments - - -
otherInvestingActivities - - -
netCashProvidedByInvestingActivities - - -
netDebtIssuance 689.39 102.18K -
longTermNetDebtIssuance - - -
shortTermNetDebtIssuance 689.39 102.18K -
netStockIssuance - - -
netCommonStockIssuance - - -
commonStockIssuance - - -
commonStockRepurchased - - -
netPreferredStockIssuance - - -
netDividendsPaid - - -
commonDividendsPaid - - -
preferredDividendsPaid - - -
otherFinancingActivities - - 400
netCashProvidedByFinancingActivities 689.39 102.18K 400